Sciele, Addrenex Partner On Novel Hypertension Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Alpha adrenergic receptor agonist will enter Phase II clinical studies in the second half of the year.
You may also be interested in...
Shionogi Buys Sciele: U.S. Sales Platform For Crestor Innovator
Japanese drug maker Shionogi is paying $1.42 billion for a U.S. marketing platform
Shionogi Buys Sciele: U.S. Sales Platform For Crestor Innovator
Japanese drug maker Shionogi is paying $1.42 billion for a U.S. marketing platform
Sciele And Addrenex Seek Hypertension Approval For Sustained-Release Clonidine
The 12-hour formulation is designed to improve clonidine’s side effect profile.